Although GRP78/BiP levels are elevated in many cancer cells and human cancers and closely associated with malignancy, metastasis, and chemotherapeutic resistance [22,23], few studies have evaluated its prognostic significance in patients with breast, lung, gastric, hepatocellular, or prostate cancer [23]. The gene discussed is HSPA5; the disease is cancer.